Abstract:Genome editing based on programmable nucleases and donor DNA constructs permits introducing specific base-pair changes and complete transgenes or live-cell reporter tags at predefined chromosomal positions. A crucial requirement for such versatile genome editing approaches is, however, the need to co-deliver in an effective, coordinated and non-cytotoxic manner all the required components into target cells. Here, adenoviral (AdV) and adeno-associated viral (AAV) vectors are investigated as delivery agents for, respectively, engineered CRISPR-Cas9 nucleases and donor DNA constructs prone to homologous recombination (HR) or homology-mediated end joining (HMEJ) processes. Specifically, canonical single-stranded and self-complementary double-stranded AAVs served as sources of ectopic HR and HMEJ substrates, whilst second- and third-generation AdVs provided for matched CRISPR-Cas9 nucleases. We report that combining single-stranded AAV delivery of HR donors with third-generation AdV transfer of CRISPR-Cas9 nucleases results in selection-free and precise whole transgene insertion in large fractions of target-cell populations (i.e. up to 93%) and disclose that programmable nuclease-induced chromosomal breaks promote AAV transduction. Finally, besides investigating relationships between distinct AAV structures and genome-editing performance endpoints, we further report that high-fidelity CRISPR-Cas9 nucleases are critical for mitigating off-target chromosomal insertion of defective AAV genomes known to be packaged in vector particles.

Targeted Genome Correction by a Single Adenoviral Vector Simultaneously Carrying an Inducible Zinc Finger Nuclease and a Donor Template

Multiple copies of a linear donor fragment released in situ from a vector improve the efficiency of zinc-finger nuclease-mediated genome editing

Precision genome editing using combinatorial viral vector delivery of CRISPR-Cas9 nucleases and donor DNA constructs

Targeted Gene Addition to A Predetermined Site in the Human Genome Using A Zfn-Based Nicking Enzyme

Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets

Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery

Application of Zinc Finger Nucleases in Genome Targeting Modification

Efficient Genome Editing Achieved via Plug-and-Play Adenovirus Piggyback Transport of Cas9/gRNA Complex on Viral Capsid Surface

Highly Efficient Homology-Driven Genome Editing in Human T Cells by Combining Zinc-Finger Nuclease Mrna and AAV6 Donor Delivery.

Progress in zinc finger nuclease engineering for targeted genome modification]

Intracellular Generation of Single-Strand Template Increases the Knock-in Efficiency by Combining CRISPR/Cas9 with AAV

Targeted Gene Correction Directed by Chimeric RNA/DNA Oligonucleotides

Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo

In Vivo Delivery Systems for Therapeutic Genome Editing.

Adenine Base Editing in vivo with a Single Adeno-Associated Virus Vector

A suicidal zinc finger nuclease expression coupled with a surrogate reporter for efficient genome engineering

Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction

Improving the Efficiency of Precise Genome Editing with Site-Specific Cas9-oligonucleotide Conjugates

Engineering a Transposon-Associated TnpB-ωRNA System for Efficient Gene Editing and Phenotypic Correction of a Tyrosinaemia Mouse Model

Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

Nanobiomaterial Vectors for Improving Gene Editing and Gene Therapy